These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35794221)

  • 1. Risk factors for metabolic syndrome in individuals with recent-onset psychosis at disease onset and after 1-year follow-up.
    Alonso Y; Miralles C; Algora MJ; Valiente-Pallejà A; Sánchez-Gistau V; Muntané G; Labad J; Vilella E; Martorell L
    Sci Rep; 2022 Jul; 12(1):11386. PubMed ID: 35794221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders - Baseline and two-years findings from the CHANGE trial.
    Storch Jakobsen A; Speyer H; Nørgaard HCB; Hjorthøj C; Krogh J; Mors O; Nordentoft M
    Schizophr Res; 2018 Sep; 199():96-102. PubMed ID: 29501386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and related factors in a large sample of antipsychotic naïve patients with first-episode psychosis: 3 years follow-up results from the PAFIP cohort.
    Garrido-Torres N; Ruiz-Veguilla M; Olivé Mas J; Rodríguez Gangoso A; Canal-Rivero M; Juncal-Ruiz M; Gómez-Revuelta M; Ayesa-Arriola R; Crespo-Facorro B; Vázquez-Bourgon J
    Span J Psychiatry Ment Health; 2023; 16(3):175-183. PubMed ID: 38520081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and aerobic fitness in patients with first-episode schizophrenia, including a 1-year follow-up.
    Nyboe L; Vestergaard CH; Moeller MK; Lund H; Videbech P
    Schizophr Res; 2015 Oct; 168(1-2):381-7. PubMed ID: 26278336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cannabis use on body mass, fasting glucose and lipids during the first 12 months of treatment in schizophrenia spectrum disorders.
    Scheffler F; Kilian S; Chiliza B; Asmal L; Phahladira L; du Plessis S; Kidd M; Murray RM; Di Forti M; Seedat S; Emsley R
    Schizophr Res; 2018 Sep; 199():90-95. PubMed ID: 29519756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid alterations in adolescents with early-onset psychosis may be independent of antipsychotic medication.
    Wedervang-Resell K; Friis S; Lonning V; Smelror RE; Johannessen C; Agartz I; Ulven SM; Holven KB; Andreassen OA; Myhre AM
    Schizophr Res; 2020 Feb; 216():295-301. PubMed ID: 31791814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ziprasidone on metabolic syndrome risk factors in subjects with schizophrenia: a 1 year, open-label, prospective study.
    Chue P; Mandel FS; Therrien F
    Curr Med Res Opin; 2014 Jun; 30(6):997-1005. PubMed ID: 24568177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome following a first episode of psychosis: results of a 1-year longitudinal study conducted in metropolitan Lisbon, Portugal.
    Coentre R; Levy P; Góis C; Figueira ML
    J Int Med Res; 2022 Jun; 50(6):3000605221106703. PubMed ID: 35726606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in serum HDL level is associated with less negative symptoms after one year of antipsychotic treatment in first-episode psychosis.
    Gjerde PB; Dieset I; Simonsen C; Hoseth EZ; Iversen T; Lagerberg TV; Lyngstad SH; Mørch RH; Skrede S; Andreassen OA; Melle I; Steen VM
    Schizophr Res; 2018 Jul; 197():253-260. PubMed ID: 29129510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follow-ups of metabolic, inflammatory and oxidative stress markers, and brachial-ankle pulse wave velocity in middle-aged subjects without metabolic syndrome.
    Kim OY; Paik JK; Lee JY; Lee SH; Lee JH
    Clin Exp Hypertens; 2013; 35(5):382-8. PubMed ID: 23148723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in patterns of metabolic abnormality and metabolic syndrome between early-onset and adult-onset first-episode drug-naive schizophrenia patients.
    Lang X; Zhou Y; Zhao L; Gu Y; Wu X; Zhao Y; Li Z; Zhang X
    Psychoneuroendocrinology; 2021 Oct; 132():105344. PubMed ID: 34274733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between smoking, components of metabolic syndrome and lipoprotein particle size.
    Slagter SN; van Vliet-Ostaptchouk JV; Vonk JM; Boezen HM; Dullaart RP; Kobold AC; Feskens EJ; van Beek AP; van der Klauw MM; Wolffenbuttel BH
    BMC Med; 2013 Sep; 11():195. PubMed ID: 24228807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of the incident metabolic syndrome in healthy obese subjects: a decade of follow-up from the Tehran Lipid and Glucose Study.
    Hosseinpanah F; Nazeri P; Ghareh S; Tohidi M; Azizi F
    Eur J Clin Nutr; 2014 Mar; 68(3):295-9. PubMed ID: 23963276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psoriasis and metabolic syndrome in children: current data.
    Pietrzak A; Grywalska E; Walankiewicz M; Lotti T; Roliński J; Myśliński W; Chabros P; Piekarska-Myślińska D; Reich K
    Clin Exp Dermatol; 2017 Mar; 42(2):131-136. PubMed ID: 28044372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: results from the CLAMORS study.
    Bobes J; Arango C; Aranda P; Carmena R; Garcia-Garcia M; Rejas J;
    Eur Psychiatry; 2012 May; 27(4):267-74. PubMed ID: 21036549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomere length as a marker of cellular aging is associated with prevalence and progression of metabolic syndrome.
    Révész D; Milaneschi Y; Verhoeven JE; Penninx BW
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4607-15. PubMed ID: 25188715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective association between the dietary inflammatory index and metabolic syndrome: findings from the SU.VI.MAX study.
    Neufcourt L; Assmann KE; Fezeu LK; Touvier M; Graffouillère L; Shivappa N; Hébert JR; Wirth MD; Hercberg S; Galan P; Julia C; Kesse-Guyot E
    Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):988-96. PubMed ID: 26482566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome.
    Glueck CJ; Papanna R; Wang P; Goldenberg N; Sieve-Smith L
    Metabolism; 2003 Jul; 52(7):908-15. PubMed ID: 12870169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The causal role of elevated uric acid and waist circumference on the risk of metabolic syndrome components.
    Biradar MI; Chiang KM; Yang HC; Huang YT; Pan WH
    Int J Obes (Lond); 2020 Apr; 44(4):865-874. PubMed ID: 31754239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.